[ad_1]
- date:
- March 1, 2024
- time:
-
9:00 am – 4:30 pm (Eastern Time)
Register
generalize
The FDA will host Rare Disease Day, a virtual public meeting on March 1, 2024, to commemorate Global Rare Disease Week. This year’s Rare Disease Day is dedicated to patients and healthcare professionals. The group will discuss:
- FDA’s legal framework for approving research and medical products
- What the FDA does during the review process for approving medical products
- Decentralized clinical trials and digital health technologies
- Where to find important information and documents related to clinical trials
- Information available from medical product labels
- Legal and ethical requirements for clinical trial consent
- FDA Initiatives to Advance Medical Product Development for Rare Diseases
- How patients interact with the FDA
agenda and materials
View the agenda (PDF, 2.39 MB) for details about this event, including speaker biographies. When available, each speaker’s slides are provided below under the event materials.
continuing education credits
Physicians, physician assistants, pharmacists, pharmacy technicians, nurses and certified public health professionals who participate in FDA Rare Disease Day can receive free continuing education (CE) credits. Activities are approved for 4.25 CE credits. For more information, see the event outline and CE credit application instructions (PDF, 436.98 KB).
public docket
Stakeholders are invited to provide their views on the issues discussed through a public summary. All comments until April 5, 2024 must be marked with docket number FDA-2023-N-5211.
touch
Participants can submit questions in advance to OOPDOrphanEvents@fda.hhs.gov.
Office of Clinical Policy and Planning, Office of Orphan Products Development | 301-796-7634
[ad_2]
Source link